

NCT02573168 Raw comparison:

Summary:
CHIA has 22 criteria while your personal folder has 29 criteria
Total found criteria: 20/22
Total not Found: 2/22
Total Extra: 7
This trial is INVALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ 18 years of age or older                           │ 18 years of age or older                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Be capable and willing to provide written informed │ Be capable and willing to provide written informed │
│ consent to participate in this study               │ consent to participate in this study               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Agree to abide by the study protocol and its       │ Agree to abide by the study protocol and its       │
│ restrictions and be able to complete all aspects   │ restrictions and be able to complete all aspects   │
│ of the study including all visits and tests        │ of the study including all visits and tests        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients posing a serious suicidal risk and/or     │ Patients posing a serious suicidal risk and/or     │
│ violence as judged by the investigator             │ violence as judged by the investigator             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Delirium                                           │ Delirium                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Dementia                                           │ Dementia                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Amnestic and other cognitive disorder              │ Amnestic and other cognitive disorder              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a history of hypothyroidism unless   │ Patients with a history of hypothyroidism unless   │
│ taking a stable dose of thyroid medication and     │ taking a stable dose of thyroid medication and     │
│ asymptomatic or euthyroid for 6 months             │ asymptomatic or euthyroid for 6 months             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who meet DSM-IV-TR criteria for any       │ Patients who meet DSM-IV-TR criteria for any       │
│ significant current substance abuse                │ significant current substance dependence           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ hepatic insufficiency (three times the upper limit │ hepatic insufficiency (three times the upper limit │
│ of normal (ULN) for aspartate aminotransferase     │ of normal (ULN) for aspartate aminotransferase     │
│ (AST) and/or alanine aminotransferase (ALT)) liver │ (AST) and/or alanine aminotransferase (ALT)) liver │
│ transplant recipient cirrhosis of the liver        │ transplant recipient cirrhosis of the liver        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ malignancy (except basal cell carcinoma) and/or    │ malignancy (except basal cell carcinoma) and/or    │
│ chemotherapy within 1 year prior to screening      │ chemotherapy within 1 year prior to screening      │
│ malignancy more than 1 year prior to screening     │ malignancy more than 1 year prior to screening     │
│ must have been local and without metastasis and/or │ must have been local and without metastasis and/or │
│ recurrence and if treated with chemotherapy        │ recurrence and if treated with chemotherapy        │
│ without nervous system complications               │ without nervous system complications               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ significant unstable medical condition or life     │ significant unstable medical condition or life     │
│ threatening disease with anticipated survival of   │ threatening disease with anticipated survival of   │
│ less than 6 months                                 │ less than 6 months                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ need for therapies that may obscure the results of │ need for therapies that may obscure the results of │
│ treatment and/or of the study                      │ treatment and/or of the study                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Participation in another clinical trial within 30  │ Participation in another clinical trial within 30  │
│ days of the screening visit                        │ days of the screening visit                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Anticipated inability to attend scheduled study    │ Anticipated inability to attend scheduled study    │
│ visits                                             │ visits                                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who in the judgment of the Investigator   │ Patients who in the judgment of the Investigator   │
│ may be unreliable or uncooperative with the        │ may be unreliable or uncooperative with the        │
│ evaluation procedure outlined in this protocol     │ evaluation procedure outlined in this protocol     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a history of prior pharmacogenomic   │ Patients with a history of prior pharmacogenomic   │
│ testing                                            │ testing                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any change in psychotropic medication (including   │ Any change in psychotropic medication (including   │
│ change in dosage) between screening and baseline   │ change in dosage) between screening and baseline   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who are known to be pregnant or lactating │ Patients who are known to be pregnant or lactating │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a history of gastric bypass surgery  │ Patients with a history of gastric bypass surgery  │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



╒═════════════════════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                                             │
╞═════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Suffer from schizophrenia/schizoaffective disorder meeting Diagnostic and Statistical Manual of │
│ Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) criteria                              │
├─────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Have a total baseline score on the Brief Psychiatric Rating Scale (BPRS) = 45                   │
╘═════════════════════════════════════════════════════════════════════════════════════════════════╛



╒══════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                              │
╞══════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Patients with                                                                                        │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Suffer from schizophrenia schizoaffective disorder schizophreniform disorder psychosis not otherwise │
│ specified bipolar disorder (I II NOS) or major depressive disorder meeting Diagnostic and            │
│ Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) criteria             │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Intending to switch to or start a new antipsychotic medication                                       │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Have moderate to severe psychiatric symptoms                                                         │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Patients who are on restricted diets (e g diabetes) who have an eating restriction disorder (e g     │
│ bulimia anorexia) or who are undergoing weight-reducing interventions (e g metformin or structured   │
│ diet program)                                                                                        │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                    │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Patients with a current Axis I diagnosis of                                                          │
╘══════════════════════════════════════════════════════════════════════════════════════════════════════╛